Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1817 of 6351
-
Ovarian cancer drug combo trial halted early – what we know
Disease control Stopped earlyThis is a Phase 1b/2a, open-label, adaptive-design outpatient study to assess the safety, tolerability, and PK/PD of SON-1010 in combination with atezolizumab administered to patients with advanced solid tumors (Part 1) and patients with Platinum-resistant Ovarian Cancer (Part 2)
Phase 1/2 • Sponsor: Sonnet BioTherapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Herbal granules may boost IVF success for women over 35
Disease control CompletedThis randomized controlled trial aims to determine whether Erzhi Tiangui Formula can optimize the reproductive outcomes of elderly patients with expected poor ovarian response, and to provide a new approach to traditional Chinese medicine assisted in vitro fertilization and embry…
Sponsor: Shandong University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New obesity injection shows promise in early trial
Disease control CompletedThe purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could diabetes drugs also protect kidneys by fixing fat?
Disease control Recruiting nowChronic kidney disease (CKD) is the progressive damage to kidney function, associated with an increased risk of cardiovascular diseases, such as stroke or myocardial infarct, particularly in the most severe stages of CKD, in which the patient requires dialysis. Several risk facto…
Sponsor: Cardenal Herrera University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Numbing cream may ease pain of IUD insertion and biopsies
Symptom relief CompletedThe goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (…
Phase 4 • Sponsor: CAMC Health System • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New implant combo aims to lower eye pressure without daily drops
Disease control Recruiting nowAdult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Phase 4 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New HER2-Targeting drug shows promise in early cancer trial
Disease control Recruiting nowThis study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of IKS014, a HER2 targeting antibody-drug conjugate, in patients with advanced solid tumors.
Phase 1 • Sponsor: Iksuda Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail takes on tough pancreatic cancer
Disease control Recruiting nowThis is an open-label Phase I/Ib dose-escalation, dose-expansion clinical trial of the safety, pharmacokinetics and clinical activity of ProAgio combined with gemcitabine, nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subject…
Phase 1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Phone app aims to ease emotional burden for Alzheimer's caregivers
Symptom relief Recruiting nowAlzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) not only exact a heavy toll on patients, they also impose an enormous emotional, physical, and financial burden on unpaid, often family, caregivers. The strain of providing care for a loved one diagnosed wi…
Sponsor: Bryan Denny • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Personalized interferon therapy aims to tame kidney disease without weakening defenses
Disease control Stopped earlyMembranous Nephropathy (MN) is a renal autoimmune disease mediated by autoantibodies. Current management is based on the use of immunosuppressive therapies. MN patients with a pro-inflammatory Th17 cytokine profile have a 10.5-fold increased risk of disease relapse. Interferon-ba…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to melt liver fat in NASH patients
Disease control Recruiting nowEvaluate efficacy and safety of ADI-PEG 20 in patients with NASH
Phase 2 • Sponsor: Polaris Group • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cord blood transfusions show promise for tiniest babies
Disease control CompletedThis study has been designed to demonstrate that red blood cell from umbilical cord blood (UCB-RBC) is a safe and available product for extremely preterm infants (EPI) transfusion and that transfusion of UCB-RBC is non-less effective than RBC from adult donor for the treatment of…
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New heart pump device aims to make risky procedures safer
Disease control OngoingThe objective is to assess the feasibility and safety of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing high-risk percutaneous interventions (HRPCI).
Sponsor: Supira Medical • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Tiny needle patch takes aim at skin cancer
Disease control Recruiting nowThe purpose of this study is to test a new method of experimental treatment for cutaneous squamous cell skin cancer, using small adhesive-like patches (a micro-needle applicator or MNA for short), which have dozens of very small micro-needles loaded with extremely low doses of do…
Phase 1/2 • Sponsor: Falo, Louis, MD • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control OngoingThis is an Open-label, multicenter clinical study conducted in two Phases to establish the efficacy, safety, tolerability, and pharmacokinetics of the ataxia telangiectasia mutated and Rad3-related protein kinase (ATR) inhibitor Tuvusertib in Combination with Cemiplimab in Partic…
Phase 1/2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can zoom mindfulness classes keep alcohol addiction at bay?
Disease control OngoingThis project will evaluate the effectiveness and mechanisms of mindfulness-based relapse prevention (MBRP) delivered via video conferencing, as compared to referral to online mutual support groups, in supporting long-term whole-person recovery and improvements in neurobiologicall…
Sponsor: University of New Mexico • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThe purpose of this study is to demonstrate safety and effectiveness of the ablation system (OMNYPULSE Bi-directional catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participants with paroxysmal atrial fibrillation (PAF…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
PCOS fertility boost? supplement myo-inositol tested in major trial
Disease control Recruiting nowThe main objective will be to check if MyoInositol (MYO) reduces the total resistance rate to Clomiphene Citrate (CC). For this, our study will be controlled, randomized and double blinded. It will include patients with PCOS (polycystic ovary syndrome, defined by the Rotterdam cr…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for advanced breast cancer: experimental drug FWD1802 enters human trials
Disease control Recruiting nowA Phase I/II, Open-label study to assess the safety, tolerability, pharmacokinetic, and antitumor efficacy of FWD1802 monotherapy in patients with ER+/HER2- unresectable locally advanced or metastatic breast cancer. This clinical trial aims to explore the role of FWD1802 in the E…
Phase 1/2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
App aims to boost motivation in schizophrenia patients
Symptom relief CompletedThe purpose of the proposed an open label extension (OLE) study is to evaluate the maintained efficacy and safety of a second consecutive course of Click Therapeutics Study App as an adjunct treatment to standard of care (SOC) in participants who were on the Study App and have re…
Phase 3 • Sponsor: Click Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC